Profile

Richard P. McQuellon, Ph.D.Wake Forest School of Medicine

Doctor Rating

No Rating Available
Why No Ratings?

Richard P. McQuellon, Ph.D.

Professor,

Clinical Interests

Psychosocial Oncology, Quality of Life, Depression in Cancer Patients

Contact Information

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-713-5440
Department: 336-716-4464

Insurance Accepted »

Education & Training

  • B.S., University of Washington, 1971
  • M.A., Appalachian State University, 1974
  • Ph.D., Michigan State University, 1983
  • Internship, Psychology, Ingham Medical Center, 1983

Memberships

  • Am Assn Of Marriage & Family T
  • Am Psychological Assn
  • Am Soc Of Hypertension
  • Canadian Society For Immunolog
  • Eastern Gut Club
  • Forsyth Co. Psychological Soci

NPI Number

  • 1275518623
Richard P. McQuellon, Ph.D.

Doctor Rating

No Rating Available
Why No Ratings?

Richard P. McQuellon, Ph.D.

Professor, Hematology & Oncology
Psychiatry and Behavioral Medicine

Research Interests

Quality of Life; Peritoneal Neoplasms; Hyperthermia, Induced; Chemotherapy, Cancer, Regional Perfusion; Neoplasms
More »

Contact Information

Academic: 336-716-7980 | Department: 336-716-4464

Recent Publications

Association of survival, postoperative morbidity and mortality following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy using quality of life assessments [abstract]. Dodson RM, Mogal H, Russell G, Duckworth KE, Votanopoulos K, Shen P, Levine EA, McQuellon RP.. Ann Surg Oncol. 2016;23(Suppl 1):S35.

Measuring meaning and peace with the FACIT-Spiritual Well-Being Scale: distinction without a difference?. Peterman AH, Reeve CL, Winford EC, Cotton S, Salsman JM, McQuellon R, Tsevat J, Campbell C.. Psychol Assess. 2014;26(1):127-137.

Fear of cancer recurrence, distress and depressive symptoms in hematopoietic stem cell transplantation patients [abstract]. McQuellon R, Campbell C, Duckworth K, Russell G, Naik S, Williams A, Zamkoff K, Hurd D.. Psychooncology. 2014;23(Suppl 1):3-4.

Hematopoietic stem cell transplant candidate and designated proxy distress levels prior to hematopoietic stem cell transplantation. Duckworth KE, Forti AM, Russell GB, Naik S, Hurd DD, McQuellon RP.. Am J Hosp Palliat Care. 2014;31(8):853-856.

The process of advance care planning in HCT candidates and proxies: self-efficacy, locus of control, and anxiety levels. Duckworth KE, Forti AM, Russell GB, Naik S, Hurd D, McQuellon RP.. Am J Hosp Palliat Care. 2014;31(7):710-716.

Post-traumatic growth is sustained two years after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy [abstract]. Addington E, Russell G, Tedeschi R, Levine E, Shen P, Stewart J, Danhauer S, Duckworth K, McQuellon R.. Psychooncology. 2013;22(Suppl 2):54.

Advance care planning information and distress in hematopoietic cell transplant candidates and proxies [abstract]. Duckworth K, Forti A, Russell G, Campbell C, Naik S, Hurd D, McQuellon R.. Psychooncology. 2013;22(Suppl 2):100-101.

Survivorship programming in an academic medical center [abstract]. Williams A, Winford E, Addington E, Scott T, Mcquellon R.. Psychooncology. 2013;22(Suppl 2):123-124.

Patient preparedness and treatment satisfaction following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CS+HIPEC) [abstract]. Duckworth K, McQuellon R, Russell G, Campbell C, Shen P, Stewart J IV, Levine E.. Psychooncology. 2013;22(Suppl 2):54-55.

Predicting postoperative morbidity following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CS+HIPEC) with preoperative FACT-C (Functional Assessment of Cancer Therapy) and patient-rated performance status. Ihemelandu CU, McQuellon R, Shen P, Stewart JH, Votanopoulos K, Levine EA.. Ann Surg Oncol. 2013;20(11):3519-3526.

A phase II trial of thalidomide and procarbazine in adult patients with recurrent or progressive malignant gliomas. Ruiz J, Case D, Enevold G, Rosdhal R, Tatter SB, Ellis TL, McQuellon RP, McMullen KP, Stieber VW, Shaw EG, Lesser GJ.. J Neurooncol. 2012;106(3):611-617.

Inpatient consultation with cancer patients: a guide for oncology counselors [abstract]. Groleau J, Horn G, Campbell C, McQuellon R.. Psychooncology. 2012;21(Suppl 1):44.

After screening for depression in a high risk medical population: then what? [abstract]. McQuellon R, Duckworth K, Russell G, Shen P, Stewart J, Votanopoulos K, Levine E.. Psychooncology. 2012;21(Suppl 1):126-127.

Fear of recurrence following hematopoetic stem cell transplantation [abstract]. McQuellon R, Duckworth K, Campbell C, Russell G, Naik S, Levitan D, Zamkoff K, McQuellon BT, Hurd D.. Psychooncology. 2012;21(Suppl 1):127.

Quality of life and survival in advanced cervical cancer: a Gynecologic Oncology Group study. Chase DM, Huang HQ, Wenzel L, Cella D, McQuellon R, Long HJ, Moore DH, Monk BJ.. Gynecol Oncol. 2012;125(2):315-319.

Patient rated outcomes and survivorship following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CS + HIPEC). Duckworth KE, McQuellon RP, Russell GB, Cashwell CS, Shen P, Stewart JH IV, Levine EA.. J Surg Oncol. 2012;106(4):376-380.

Predicting postoperative morbidity following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CS plus HIPEC) with preoperative FACT - C (Functional Assessment of Cancer Therapy) and patient rated performance status [abstract]. Ihemelandu CU, Shen P, Stewart JH, Votanopoulos K, McQuellon R, Russell G, Levine EA.. Ann Surg Oncol. 2012;19(Suppl 1):S16.

Fee-for-service payment for counseling in a comprehensive cancer center [abstract]. McQuellon R, Horn G, Campbell C, Duckworth K.. Psychooncology. 2011;20(Suppl 1):17-18.

Quality of life and sleep quality of long-term survivors of cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy [abstract]. Duckworth K, McQuellon R, Russell G, Levine E, Shen P, Stewart J, Cromer M, Cashwell C.. Psychooncology. 2011;20(Suppl 1):79-80.

Health related quality of life, depressive symptoms and distress before and after hematopoietic cell transplantation [abstract]. Campbell C, McQuellon R, Duckworth K, Russell G, Hurd D, Levitan D, Naik S, Zamkoff K, McQuellon B, Sommer J.. Psychooncology. 2011;20(Suppl 1):81.

Survival and quality of life following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colonic origin. Hill AR, McQuellon RP, Russell GB, Shen P, Stewart JH IV, Levine EA.. Ann Surg Oncol. 2011;18(13):3673-3679.

Quality of survivorship, surveillance behavior and treatment satisfaction following hematopoietic cell transplantation [abstract]. McQuellon R, Campbell C, Russell G, Duckworth K, Sommer J, McQuellon B, Hurd D.. Psychooncology. 2010;19(Suppl 1):S98-S99.

The role of the oncology counselor in cancer interdisciplinary team meetings [abstract]. Horn G, Campbell C, Cangin M, Duckworth K, McQuellon R.. Psychooncology. 2010;19(Suppl 1):S65.

Multi-site study of caregiver outcomes during hemtopoietic cell transplantation (HCT) [abstract]. Yi JC, Syrjala KL, Abrams JR, Silver S, Tierney DK, Matous J, Wingard JR, Dansey R, McQuellon R, Langer SL.. Ann Behav Med. 2010;39(Suppl 1):s201.

. McQuellon RP, Cowan MA. In: The art of conversation through serious illness: lessons for caregivers. New York: Oxford University Press;2010: .

Survival and health-related quality of life following cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for disseminated peritoneal cancer of colonic origin [abstract]. Hill AR, McQuellon RP, Russell GB, Shen P, Stewart JH, Levine EA.. Ann Surg Oncol. 2010;17(Suppl 1):S9.

Aprepitant/5HT-3 antagonist (EMEND) for the prevention of chemoradiation-induced nausea and vomiting (CRINV) in patients receiving gemcitabine/5-FU-based chemoradiation and concurrent upper abdominal radiation for pancreatic cancer [abstract]. Blackstock AW, Aklilu M, Lovato J, Degrass L, Sommer J, Howerton R, Mishra G, Levine E, McQuellon R.. J Clin Oncol. 2009;27(Suppl):e20661.

Integrating psychosocial care and research in a comprehensive cancer center [abstract]. McQuellon R, Campbell C, Cangin M, Horn G, Duckworth K.. Psychooncology. 2009;18(Suppl 1):S42.

Assessing depressive symptoms with the Center for Epidemiologic Studies Depression Scale prior to cytoreductive surgery + intraperitoneal hyperthermic chemotherapy [abstract]. McQuellon R, Russell G, Campbell C, Duckworth K, Shen P, Stewart J, Fenstermaker J, Pruitt L, Cromer M, Levine E, et al.. Psychooncology. 2009;18(Suppl 1):S42-S43.

Assessing distress and depression in hematopoietic stem cell transplant patients [abstract]. McClure White G, Campbell C, Russell G, Duckworth K, Hurd D, McQuellon R.. Psychooncology. 2009;18(Suppl 1):S43.

Psychosocial issues in hematopoietic cell transplantation. McQuellon RP, Andrykowski M. In: Appelbaum FR, Forman SJ, Negrin RS, Blume KG, eds. Thomas' hematopoietic cell transplantation: stem cell transplantation. 4th ed. Oxford (UK): Wiley-Blackwell;2009: 488-501.

Health-related quality of life and cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy. McQuellon R, Duckworth KE.. Curr Probl Cancer. 2009;33(3):203-218.

Survival and health outcomes after cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of appendiceal origin. McQuellon RP, Russell GB, Shen P, Stewart JH IV, Saunders W, Levine EA.. Ann Surg Oncol. 2008;15(1):125-133.

Quality of life and nutritional assessment in peritoneal surface malignancy (PSM): recommendations for care. McQuellon R, Gavazzi C, Piso P, Swain D, Levine E.. J Surg Oncol. 2008;98(4):300-305.

Restorative yoga for women with breast cancer: findings from a randomized pilot study [abstract]. Danhauer SC, Russell G, Campbell CR, Daley KL, McQuellon RP, Levine E.. Ann Behav Med. 2008;35(Suppl 1):S103.

Restorative yoga for women with ovarian or breast cancer: findings from a pilot study. Danhauer SC, Tooze JA, Farmer DF, Campbell CR, McQuellon RP, Barrett R, Miller BE.. J Soc Integr Oncol. 2008;6(2):47-58.

A phase III randomized study comparing the effects of oxandrolone (Ox) and megestrol acetate (Meg) on lean body mass (LBM), weight (wt) and quality of life (QOL) in patients with solid tumors and weight loss receiving chemotherapy [abstract]. Lesser GJ, Case D, Ottery F, McQuellon R, Choksi JK, Sanders G, Rosdhal R, Shaw EG.. J Clin Oncol. 2008;26(15 Suppl Pt I):505s.

Music or guided imagery for women undergoing colposcopy: a randomized controlled study of effects on anxiety, perceived pain, and patient satisfaction. Danhauer SC, Marler B, Rutherford CA, Lovato JF, Asbury DY, McQuellon RP, Miller BE.. J Low Genit Tract Dis. 2007;11(1):39-45.

Monitoring health outcomes following cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. McQuellon RP, Danhauer SC, Russell GB, Shen P, Fenstermaker J, Stewart JH, Levine EA.. Ann Surg Oncol. 2007;14(3):1105-1113.

Providing psychosocial group support for young women with breast cancer: findings from a wellness-based community collaboration. Danhauer SC, Rutherford CA, Hurt G, Gentry S, Lovato J, McQuellon RP.. J Psychosoc Oncol. 2007;25(1):103-120.

Survival and quality of life (QOL) after cytoreductive surgery with intraperitoneal hyperthermic chemotherapy (IPHC) for disseminated peritoneal cancer (PC) of appendiceal origin [abstract]. McQuellon RP, Russell GB, Shen P, Stewart JH, Saunders WW, Levine EA.. Ann Surg Oncol. 2007;14(2 Suppl):30-31.

Treatment of low-risk myelodysplastic syndromes with high-dose daily oral cholecalciferol (2000-4000 IU vitamin D(3)) [letter]. Molnar I, Stark N, Lovato J, Powell BL, Cruz J, Hurd DD, Mathieu JS, Cambra S, McQuellon RP, Schwartz GG, et al.. Leukemia. 2007;21(5):1089-1092.

Social support, optimism, and self-efficacy predict physical and emotional well-being after bone marrow transplantation. Hochhausen N, Altmaier EM, McQuellon R, Davies SM, Papadopolous E, Carter S, Henslee-Downey J.. J Psychosoc Oncol. 2007;25(1):87-101.

A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy. Butler JM Jr, Case LD, Frizzell B, Lesser G, McMullen K, McQuellon R, Naughton M, Rapp S, Stieber V, Shaw EG, et al.. Int J Radiat Oncol Biol Phys. 2007;69(5):1496-1501.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Hematology & Oncology

Clinical Interests

Psychosocial Oncology, Quality of Life, Depression in Cancer Patients
Richard P. McQuellon, Ph.D.

Richard P. McQuellon, Ph.D.

Professor, Hematology & Oncology
Psychiatry and Behavioral Medicine

CP concern for questions/worries
4.9
CP efforts to include in decisions
4.9
CP explanations of prob/condition
4.9
CP spoke using clear language
4.9
Friendliness/courtesy of CP
4.9
Likelihood of recommending CP
4.9
Patients' confidence in CP
4.8
Time CP spent with patient
4.9
Wait time at clinic
4.6



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

5/5/2016

Very helpful.

12/20/2015

He's been really great, I would recommend him to anyone!

9/30/2015

Dick McQuellon is a fantastic caregiver/therapist. He has been such a source of comfort to me during a very difficult time dealing with a very sick husband.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
Magnet Hospital RecognitionConsumer Choice2015 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.